Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$25.3 - $39.67 $5.03 Million - $7.88 Million
-198,649 Reduced 65.17%
106,171 $2.94 Million
Q1 2023

May 03, 2023

SELL
$30.21 - $48.1 $3.16 Million - $5.04 Million
-104,754 Reduced 25.58%
304,820 $10.2 Million
Q4 2022

Feb 06, 2023

BUY
$22.28 - $38.71 $4.12 Million - $7.15 Million
184,715 Added 82.15%
409,574 $12.7 Million
Q3 2022

Nov 07, 2022

SELL
$34.2 - $51.69 $2.17 Million - $3.27 Million
-63,349 Reduced 21.98%
224,859 $7.96 Million
Q2 2022

Aug 03, 2022

SELL
$23.14 - $49.68 $1.47 Million - $3.16 Million
-63,621 Reduced 18.08%
288,208 $9.68 Million
Q1 2022

May 06, 2022

BUY
$27.77 - $64.4 $7.76 Million - $18 Million
279,599 Added 387.1%
351,829 $15.2 Million
Q4 2021

Feb 11, 2022

SELL
$54.9 - $105.21 $51.9 Million - $99.5 Million
-945,786 Reduced 92.9%
72,230 $4.85 Million
Q3 2021

Nov 04, 2021

SELL
$105.0 - $178.37 $12.3 Million - $20.9 Million
-117,351 Reduced 10.34%
1,018,016 $108 Million
Q2 2021

Aug 06, 2021

BUY
$125.11 - $180.0 $8.87 Million - $12.8 Million
70,927 Added 6.66%
1,135,367 $198 Million
Q1 2021

May 10, 2021

SELL
$126.27 - $191.71 $45.5 Million - $69.1 Million
-360,192 Reduced 25.28%
1,064,440 $141 Million
Q4 2020

Feb 11, 2021

SELL
$81.94 - $135.34 $18.7 Million - $30.9 Million
-228,188 Reduced 13.81%
1,424,632 $188 Million
Q3 2020

Nov 03, 2020

SELL
$73.3 - $89.48 $7.06 Million - $8.62 Million
-96,364 Reduced 5.51%
1,652,820 $134 Million
Q2 2020

Aug 04, 2020

BUY
$48.82 - $82.53 $12.5 Million - $21.2 Million
256,535 Added 17.19%
1,749,184 $141 Million
Q1 2020

May 12, 2020

BUY
$39.1 - $62.9 $58.4 Million - $93.9 Million
1,492,649 New
1,492,649 $77.2 Million
Q1 2020

May 08, 2020

SELL
$39.1 - $62.9 $32.4 Million - $52.1 Million
-828,949 Closed
0 $0
Q4 2019

May 12, 2020

BUY
$29.79 - $43.06 $24.7 Million - $35.7 Million
828,949 New
828,949 $34.5 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.75B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Zeal Asset Management LTD Portfolio

Follow Zeal Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeal Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Zeal Asset Management LTD with notifications on news.